Heterogeneous Streptomycin Resistance Level Among Mycobacterium tuberculosis Strains From the Same Transmission Cluster

• Published in: Frontiers in microbiology Vol. 12; p. 659545
• Main Authors: Rocha, Deisy M. G. C., Magalhães, Carlos, Cá, Baltazar, Ramos, Angelica, Carvalho, Teresa, Comas, Iñaki, Guimarães, João Tiago, Bastos, Helder Novais, Saraiva, Margarida, Osório, Nuno S.
• Format: Journal Article
• Language: English
• Published: Frontiers Media S.A 11-06-2021
• Subjects: evolution; Microbiology; resistance; streptomycin; transmission; tuberculosis
• ISSN: 1664-302X; 1664-302X
• DOI: 10.3389/fmicb.2021.659545

Widespread and frequent resistance to the second-line tuberculosis (TB) medicine streptomycin, suggests ongoing transmission of low fitness cost streptomycin resistance mutations. To investigate this hypothesis, we studied a cohort of 681 individuals from a TB epidemic in Portugal. Whole-genome sequencing (WGS) analyses were combined with phenotypic growth studies in culture media and in mouse bone marrow derived macrophages. Streptomycin resistance was the most frequent resistance in the cohort accounting for 82.7% (
n
= 67) of the resistant
Mycobacterium tuberculosis
isolates. WGS of 149 clinical isolates identified 13 transmission clusters, including three clusters containing only streptomycin resistant isolates. The biggest cluster was formed by eight streptomycin resistant isolates with a maximum of five pairwise single nucleotide polymorphisms of difference. Interestingly, despite their genetic similarity, these isolates displayed different resistance levels to streptomycin, as measured both in culture media and in infected mouse bone marrow derived macrophages. The genetic bases underlying this phenotype are a combination of mutations in
gid
and other genes. This study suggests that specific streptomycin resistance mutations were transmitted in the cohort, with the resistant isolates evolving at the cluster level to allow low-to-high streptomycin resistance levels without a significative fitness cost. This is relevant not only to better understand transmission of streptomycin resistance in a clinical setting dominated by Lineage 4
M. tuberculosis
infections, but mainly because it opens new prospects for the investigation of selection and spread of drug resistance in general.